Enveda's $311M Funding: Boosting AI-Driven Drug Development
Enveda Biosciences has raised $311 million to drive AI-based drug development, focusing on nature-derived treatments for skin issues and weight management.
Blog
Latest news and articles
3 articles published
Posts tagged "AI in biotech"
Anthropic Acquires Coefficient Bio: A $400M Game-Changer
Anthropic's $400M acquisition of Coefficient Bio marks a pivotal moment, blending AI and biotechnology for future healthcare innovations.
ByteDance's Protenix-v1: A Game-Changer in Biomolecular Structure Prediction
ByteDance's Protenix-v1 aims to rival AlphaFold3 in biomolecular structure prediction. This open-source model could democratize access and accelerate biotech innovations.